Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity

Cancer Gene Therapy

Volumn 7, Issue 12, 2000, Pages 1519-1528

  Jones, Rebecca K ^a   Pope, Ian M ^a   Kinsella, Anne R ^a   Watson, Alastair J M ^a   Christmas, Stephen E ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Bystander effect; Granulocyte macrophage colony stimulating factor; Prodrug activated gene therapy; Tumor immunity

Indexed keywords

GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PRODRUG; THYMIDINE KINASE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOLOGY; CANCER THERAPY; CARCINOMA CELL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUICIDE GENE; TUMOR IMMUNITY; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR RESISTANCE; TUMOR VOLUME;

EID: 0034490547     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700259     Document Type: Article

References (57)

1. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
2. Antiviral activity and mechanism of action of ganciclovir
3. Ganciclovir. A review of its antiviral pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
4. Suicide genes: Past, present and future perspectives
5. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
6. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
7. The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
8. Systemic gene therapy of murine melanoma using tissue-specific expression of the HSVtk gene involves an immune component
9. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer in vivo for treatment of experimental human melanoma
10. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer
11. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
12. Prodrug-activated gene therapy: Involvement of an immunological component in the "bystander effect"
13. The role of the bystander effect in suicide gene therapy
14. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSVtk retroviral gene therapy
15. Mechanism of "bystander effect" killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment
16. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions
17. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication
18. Suicide gene therapy for colorectal liver metastasis produces a systemic antitumor immune response
19. Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses
20. Development of antitumor immunity following thymidine kinase-mediated killing of experimental brain tumors
21. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor
22. A "distant" bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor
23. Generation of an antitumor immune response in a non-immunogenic tumor: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoral cytokine expression
24. In vivo analysis of the "bystander effect": A cytokine cascade
25. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity
26. Antitumor effect induced by granulocyte-macrophage colony-stimulating factor gene-modified tumor vaccination: Comparison of adenovirus- and retrovirus-mediated genetic transduction
27. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic antitumor immune defense in the B16 melanoma model
28. Cytokine gene transduction into non-immunogenic murine tumor cells
29. Impaired tumorigenicity and decreased liver metastasis of murine neuroblastoma cells engineered to secrete interleukin-2 or granulocyte-macrophage colony-stimulating factor
30. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF
31. Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
32. Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2
33. Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
34. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
35. Superiority of interleukin- 12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice
36. Interleukin- 12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors
37. Combination gene therapy for liver metastasis of colon carcinoma in vivo
38. Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus thymidine kinase and granulocyte-macrophage colony-stimulating factor genes in murine colon cancer
39. Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF) / herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer
40. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer
41. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice
42. Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity
43. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: Sustained antitumor immunity prolongs animal survival
44. Granulocyte-macrophage colony-stimulating factor (GM-CSF): Preclinical and clinical investigations
45. Dendritic cells in antitumor immune responses
46. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells
47. B7-1 Expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10
48. A colon tumor model for anticancer agent evaluation
49. Expression of a Tat-inducible herpes simplex virus thymidine kinase gene protects acyclovir-treated CD4 cells from HIV-1 spread by conditional suicide and inhibition of reverse transcription
50. Analysis of tumor growth curves
51. Irradiated tumor cells adenovirally engineered to secrete granulocyte-macrophage colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice
52. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene
53. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product
54. Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases
55. Tumor antigen presentation by murine epidermal cells